Showing results (1-10 of 333) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|October 31, 2006
NY-ESO-1 immunotherapy for multiple myelomaSusann Szmania, Guido Tricot, Frits van Rhee
Blood and Lymphatic Cancer : Targets and Therapy|May 26, 2015
Profile of elotuzumab and its potential in the treatment of multiple myelomaYi-Chang Liu, Susann Szmania, Frits van Rhee
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.
British Journal of Haematology|July 13, 2010
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patientsQing Yi, Susann Szmania, John Freeman, et al.
Leukemia & Lymphoma|June 14, 2003
Predicting long-term survival in multiple myeloma patients following autotransplantsAthanasios B T Fassas, Frits Van Rhee, Guido Tricot
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myelomaSusann Szmania, Sacha Gnjatic, Guido Tricot, et al.
Haematologica|August 30, 2008
Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapyGuido Tricot, Bart Barlogie, Maurizio Zangari, et al.
British Journal of Haematology|October 28, 2008
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantationJumei Shi, Guido Tricot, Susann Szmania, et al.
Cytotherapy|December 22, 2010
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103Amberly Moreno-Bost, Susann Szmania, Katie Stone, et al.
Cancer|February 27, 2008
High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patientsMauricio Pineda-Roman, Bart Barlogie, Elias Anaissie, et al.
Pageof 34